124 related articles for article (PubMed ID: 8279845)
1. [State of the art of chemotherapy for adult acute leukemia in Japan].
Ohno R
Gan To Kagaku Ryoho; 1993 Dec; 20(16):2478-82. PubMed ID: 8279845
[TBL] [Abstract][Full Text] [Related]
2. Randomized study of individualized induction therapy with or without VCR, and of maintenance of 4 or 12 courses in adult AML: JALSG-AML87. Japan Adult Leukemia Study Group (JALSG).
Ohno R; Kobayashi T; Morishima Y; Hiraoka A; Imai K; Asoh N; Tsubaki K; Tomonaga M; Takahashi I; Kodera K
Leukemia; 1992; 6 Suppl 2():92-5. PubMed ID: 1578954
[TBL] [Abstract][Full Text] [Related]
3. [Progress of chemotherapy in adult acute leukemia].
Ohno R
Gan To Kagaku Ryoho; 1995 Mar; 22(4):431-6. PubMed ID: 7887634
[TBL] [Abstract][Full Text] [Related]
4. Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group.
Kobayashi T; Miyawaki S; Tanimoto M; Kuriyama K; Murakami H; Yoshida M; Minami S; Minato K; Tsubaki K; Ohmoto E; Oh H; Jinnai I; Sakamaki H; Hiraoka A; Kanamaru A; Takahashi I; Saito K; Naoe T; Yamada O; Asou N; Kageyama S; Emi N; Matsuoka A; Tomonaga M; Ohno R
J Clin Oncol; 1996 Jan; 14(1):204-13. PubMed ID: 8558199
[TBL] [Abstract][Full Text] [Related]
5. [Progress in the treatment of adult acute myeloid leukemia].
Ohno R
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1053-8. PubMed ID: 9239156
[TBL] [Abstract][Full Text] [Related]
6. No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group.
Miyawaki S; Tanimoto M; Kobayashi T; Minami S; Tamura J; Omoto E; Kuriyama K; Hatake K; Saito K; Kanamaru A; Oh H; Ohtake S; Asou N; Sakamaki H; Yamada O; Jinnai I; Tsubaki K; Takeyama K; Hiraoka A; Matsuda S; Takahashi M; Shimazaki C; Adachi K; Kageyama S; Ohno R
Int J Hematol; 1999 Aug; 70(2):97-104. PubMed ID: 10497848
[TBL] [Abstract][Full Text] [Related]
7. [Progress in the field of hematology in the last 100 years: Medical history of acute leukemia].
Ono R
Nihon Naika Gakkai Zasshi; 2002 Jul; 91(7):2084-9. PubMed ID: 12187682
[No Abstract] [Full Text] [Related]
8. [Treatment of acute leukemia].
Amaki K
Rinsho Ketsueki; 1984 Apr; 25(4):447-59. PubMed ID: 6540824
[No Abstract] [Full Text] [Related]
9. [Acute myeloid leukemia trials by Japan Adult Leukemia Study Group (JALSG)].
Miyazaki Y
Rinsho Ketsueki; 2009 Aug; 50(8):611-6. PubMed ID: 19915375
[No Abstract] [Full Text] [Related]
10. [Effect of etoposide added to individualized induction therapy of adult acute myeloid leukemia--the JALSG-AML-92 Study. Japan Adult Leukemia Study Group].
Miyawaki S; Tanimoto M; Kobayashi T; Minami S; Tamura J; Omoto E; Kuriyama K; Hatake K; Saito K; Ohno R
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1160-7. PubMed ID: 10945011
[TBL] [Abstract][Full Text] [Related]
11. [A phase III study of BHAC-MMP (behenoyl-ara-C, mitoxantrone, 6-mercaptopurine prednisolone) in acute leukemia. Hanshin Cooperative Study Group of Hematological Disorders].
Masaoka T; Shibata H; Nagai K; Kanamaru A; Horiuchi A; Kitani T; Yonezawa T; Kawagoe H; Yasunaga K
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2829-34. PubMed ID: 3530140
[TBL] [Abstract][Full Text] [Related]
12. Outcome of aggressive induction therapy in acute non-lymphocytic leukaemia.
Saikia TK; Ahuja HG; Gopal R; Nair CN; Kamat DM; Pai MR; Advani SH
J Assoc Physicians India; 1985 Mar; 33(3):203-6. PubMed ID: 4044476
[No Abstract] [Full Text] [Related]
13. [Evaluation of 58 patients with acute leukemia].
Sasaki A; Tsukaguchi M
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1303-7. PubMed ID: 1503484
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of leukemia: discussion].
Nihon Naika Gakkai Zasshi; 1992 Jul; 81(7):1081-93. PubMed ID: 1383368
[No Abstract] [Full Text] [Related]
15. [Treatment of acute promyelocytic leukemia with all-trans retinoic acid and chemotherapy--multicenter trial of the Japan Adult Leukemia Study Group (JALSG)].
Asou N; Adachi K; Tamura J; Kanamaru A; Kageyama S; Hiraoka A; Omoto E; Akiyama H; Ohno R
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1168-73. PubMed ID: 10945012
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of conventional chemotherapy and short-term intensive chemotherapy in adult acute myeloid leukemia].
Ohshima T
Rinsho Ketsueki; 1989 Aug; 30(8):1175-7. PubMed ID: 2601028
[TBL] [Abstract][Full Text] [Related]
17. [Mitoxantrone as combination chemotherapy in patients with acute leukemia. Tokai Blood Cancer Study Group].
Kimura K; Yoshikawa H; Yoshikawa S; Yamada K; Hirano M; Ikeda Y; Ohta K; Ohno R; Ohara K; Kobayashi M
Rinsho Ketsueki; 1986 Sep; 27(9):1616-27. PubMed ID: 3543435
[No Abstract] [Full Text] [Related]
18. [Mucosal injury of aclacinomycin A in patients with adult acute leukemia--comparison of BH-AC. AMP therapy and BH-AC. DMP therapy].
Takeyama H; Kataoka T; Yano K; Fukutani H; Watanabe E
Rinsho Ketsueki; 1986 Apr; 27(4):508-13. PubMed ID: 3461186
[No Abstract] [Full Text] [Related]
19. Results of aggressive chemotherapy for myelodysplastic syndromes.
Dohy H; Kyo T
Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1428-34. PubMed ID: 3247817
[No Abstract] [Full Text] [Related]
20. Association between the secondary colony-plating efficiency of blast progenitors and the remission induction outcome of acute myeloblastic leukemia patients.
Nara N
Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1624-9. PubMed ID: 3247826
[No Abstract] [Full Text] [Related]
[Next] [New Search]
